Please note: Our COVID-19 diagnostic products are for exclusive use and sale to hospitals and professional laboratories. Specific instrumentation and qualified personnel are required, which makes these kits not sellable to the public or to pharmacies. If you have a qualified lab and you need more information, you may contact our commercial team through the following email address: email@example.com
GENOMICA SAU has developed and sells two SARS-CoV-2 diagnostic kits with CE-IVD mark: CLART®COVID-19 and qCOVID-19.
CLART®COVID-19 is based on the CLART® technology patented by GENOMICA SAU. It is a multiplex RT-PCR where SARS-CoV-2 genes are amplified followed by hybridization with specific probes in low density microarrays. Due to the automation capacity of this system, up to 96 different patient samples can be processed at the same time in less than 5 hours. The kit has been validated at the National Center for Microbiology (Instituto de Salud Carlos III, Spanish National Reference Center) with a panel of 80 samples with a diagnostic sensitivity >96% and a diagnostic specificity of 98%. FLYER LINK.
qCOVID-19 is designed as a real-time multiplex RT-PCR kit where two different SARS-CoV-2 genes are amplified. It is based on Taqman probes, detected on FAM and VIC channels. The reaction of retrotranscription and amplification of cDNA is carried out in the same tube. This kit allows for the analysis of 48 samples in a single run in 1h and 30 min. This kit has also been validated at the National Center for Microbiology (Instituto de Salud Carlos III, Spanish National Reference Center) with a panel of 80 samples with a diagnostic sensitivity and a diagnostic specificity of 100%. FLYER LINK.